Lepidic predominant adenocarcinoma (LPA) (formerly known as bronchioalveolar carcinoma) has rarely been reported to cause refractory hypoxia with intrapulmonary shunting [1e7]. We describe a case who underwent the palliative strategy of intravascular right lower pulmonary artery embolisation with an 18 mm Amplatzer II vascular plug to reduce intrapulmonary shunting. This is the first report we are aware of using this minimally invasive procedure to treat this condition. 
Clinical record
A 64 year old man presented with haemoptysis and refractory hypoxia (p02 41 mmHg on FiO 2 0.8) following a short airflight. He was transferred for palliation closer to home. His history included 50 pack years smoking, asbestos exposure and weight loss. CT thorax (See Fig. 1 ) revealed extensive, dense consolidation of both lungs, bilateral hilar and subcarinal adenopathy, and centrilobular emphysema, but with no distant metastases evident. Sputum cytology reported atypical cells, favouring adenocarcinoma. He was polycythaemic with a haemoglobin of 203 g/L. He received antibiotics to treat any infective component, and glucocorticoids but without significant improvement. His oxygen saturations remained between 70 and 80% despite high flow oxygen. He was too unwell for further invasive investigations such as biopsy, or treatment such as chemotherapy (unknown ALK and EGFR status). He sought palliation and was discharged home with home oxygen approximately 10 L/min achieved via OxyMask with 2 connected oxygen concentrators.
8 months after initial diagnosis, he remained hypoxic, although his general condition remained stable (ECOG performance status 3) with no evidence of other end organ dysfunction. He was reevaluated with CT scans, respiratory function tests, arterial blood gases, VQ scan, bubble contrast echocardiogram and a 100% oxygen shunt study. The calculated shunt fraction was 25% (p02 54.1 on 100% O 2 , PCO2 38.9, SaO 2 88%. Hb195) There was no evidence of extra-pulmonary shunting. The VQ scan revealed marked perfusion to the unventilated right lower lobe, consistent with significant intrapulmonary shunting. Distant metastases were not detected and there was only marginal progression of his extensive consolidation to both lungs. Given his poor pulmonary reserve, biopsy for EGFR and ALK status was not undertaken. However after multidisciplinary discussion, the feasibility of a palliative procedure to reduce the shunt and hopefully improve his oxygenation and quality of life was considered.
With informed consent, he underwent pulmonary angiography with intrapulmonary catheterisation and temporary occlusion of the right inferior pulmonary artery which improved oxygen 
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Respiratory Medicine Case Reports Fig. 3 ). He remained stable and was discharged home 5 days post procedure. He reported marked symptomatic improvement in his ability to carry out activities of daily living. His home monitored peripheral SaO 2 were between 71 and 96 % with a median of 86%. He subsequently died 3 months later from a complicated pneumothorax and pulmonary embolism. Autopsy revealed extensive LPA involving all lobes of both lungs as well as hilar, mediastinal and retrosternal lymph nodes. There was a right upper lobe pulmonary embolus and a left upper lobe abscess colonised by aspergillus. The Amplatzer vascular plug was identified within a large vessel at the boundary of the right lower and middle lobes, with no evidence it contributed to his death.
Discussion
This is the first report we are aware of to use this minimally invasive, palliative procedure to improve shunting within a lung adenocarcinoma (lepidic predominant). There are few literature reports of LPA with refractory hypoxia from intrapulmonary shunting [1e7]. 5 reports have described 10 patients who underwent palliative surgery to correct the intrapulmonary shunt and hypoxia (see Table 1 subsequent lung transplantation [3] . Intrapulmonary shunting has also been reported in squamous cell carcinoma and carcinoid of the lung [8e11]. It is uncertain why our patient's initial dramatic oxygenation improvement was not sustained. Imaging did not reveal significant movement of the Amplatzer plug. Perhaps with his extensive bilateral lung disease, the moderate perfusion correction to unventilated lung was not enough to clearly demonstrate pO2 improvement. Despite no sustained improvement in oxygen saturation, he felt better and was more able to perform his activities of daily living. Unfortunately formal assessments of quality of life were not undertaken before and after the intervention.
The total cost of the Amplatzer II vascular plug and associated procedural costs is estimated at $1500, and bed costs approximately $2000. His home oxygen usage was unchanged but the palliative benefits of improving quality of life must not be Fig. 3 . VQ scan a) before and b) after procedure. discounted. Compared with major palliative thoracic surgical resection, intravascular stenting is less invasive and should be associated with shorter hospital stays.
Although life expectancy is unlikely to change, this procedure may also have a role as bridging therapy while awaiting more definitive treatment for selected cases with minimal disease.
Conclusion
This is a novel, minimally invasive approach to lung adenocarcinoma with lepidic pattern with refractory hypoxia from intrapulmonary shunting for symptom relief. Given the rarity of this condition, further studies with multi-centre collaboration are needed.
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